Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines

Other authors

Institut Català de la Salut

[Dávila Fajardo R] Department of Radiation Oncology, University Medical Center, Utrecht, the Netherlands. Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Division Imaging and Oncology, University Medical Center, Utrecht, the Netherlands. [Scarzello G] Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. [Gaze MN] Department of Oncology, University College London Hospitals NHS Foundation Trust, London, United Kingdom. [Boterberg T] Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium. [Cameron A] Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom. [Fuchs J] Department of Pediatric Surgery and Pediatric Urology, University Childreńs Hospital, Tuebingen, Germany. [Ramos M] Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-05-03T11:22:04Z

2024-05-03T11:22:04Z

2024-04-07



Abstract

Brachytherapy; Rhabdomyosarcoma; Soft tissue sarcoma


Braquiteràpia; Rabdomiosarcoma; Sarcoma de teixit tou


Braquiterapia; Rabdomiosarcoma; Sarcoma de tejido blando


Background and purpose The purpose of this study was to address the lack of published data on the use of brachytherapy in pediatric rhabdomyosarcoma by describing current practice as starting point to develop consensus guidelines. Materials and methods An international expert panel on the treatment of pediatric rhabdomyosarcoma comprising 24 (pediatric) radiation oncologists, brachytherapists and pediatric surgeons met for a Brachytherapy Workshop hosted by the European paediatric Soft tissue Sarcoma Study Group (EpSSG). The panel’s clinical experience, the results of a previously distributed questionnaire, and a review of the literature were presented. Results The survey indicated the most common use of brachytherapy to be in combination with tumor resection, followed by brachytherapy as sole local therapy modality. HDR was increasingly deployed in pediatric practice, especially for genitourinary sites. Brachytherapy planning was mostly by 3D imaging based on CT. Recommendations for patient selection, treatment requirements, implant technique, delineation, dose prescription, dose reporting and clinical management were defined. Conclusions Consensus guidelines for the use of brachytherapy in pediatric rhabdomyosarcoma have been developed through multicenter collaboration establishing the basis for future work. These have been adopted for the open EpSSG overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma (FaR-RMS).

Document Type

Article


Published version

Language

English

Publisher

Elsevier

Related items

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology;195

https://doi.org/10.1016/j.radonc.2024.110273

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)